Clariscan is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging or MRI in brain (intracranial), spine and associated tissues in adult and pediatric ...

Gadoterate Meglumine Injection is a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues ...

Adverse reactions The most common adverse reactions (≥ 0.2%) associated with Clariscan in clinical trials were nausea, headache, injection site pain, injection site coldness and rash.

"IV contrast for CT is not associated with increased risk of acute kidney injury." ScienceDaily. ScienceDaily, 26 January 2017. <www.sciencedaily.com / releases / 2017 / 01 / 170126142848.htm>.

IV: CT of head: 41–162mL; CT of body (single phase contrast): 41–162mL bolus inj or 81–162mL rapid infusion; max 162mL.

Allergic-like reactions to gadolinium-containing contrast injections in adults and pediatric patients (those younger than 19 years of age) are rare, according to a recent study. "When these ...

One common concern emergency medicine professionals face is the risk for acute kidney injury (AKI) secondary to the use of intravenous (IV) contrast for CT studies. Currently, emergency medicine ...